Zobrazeno 1 - 10
of 43
pro vyhledávání: '"J, Moksness"'
Autor:
J. Z. Finklestein, I Evans, A E Evans, J Moksness, Norman E. Breslow, Daniel M. Green, Giulio J. D'Angio
Publikováno v:
Journal of Pediatric Hematology/Oncology. 16:207-212
Purpose To determine the relationship between hematological toxicity and actual dose intensity of treatment of patients randomized to therapy during the first 28 months of the National Wilms' Tumor Study-4. Methods The mean minimum white blood cell c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8763ff60c92a774d2e2bea2e72763bdb
https://doi.org/10.1097/00043426-199408000-00004
https://doi.org/10.1097/00043426-199408000-00004
Publikováno v:
Medical and pediatric oncology. 27(5)
Among 6,209 patients with Wilms' tumor entered on the National Wilms' Tumor Study (NWTS), 93 patients (1.5%) from 63 families had a positive family history. In 30 of these 63 families a (half) sibling or parent of the NWTS patient was confirmed to ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::789c8121a099aa0596c979b5e2b7887c
https://pubmed.ncbi.nlm.nih.gov/8827065
https://pubmed.ncbi.nlm.nih.gov/8827065
Publikováno v:
Medical and pediatric oncology. 27(5)
The clinical behavior and outcome for any neoplasm are determined originally by its aggressiveness. As adjuvant therapy becomes increasingly effective for that neoplasm, responsiveness to therapy assumes a larger role in determining outcome. Wilms' t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc7d1ecb8bdf64905417feaaa99a23cf
https://pubmed.ncbi.nlm.nih.gov/8827069
https://pubmed.ncbi.nlm.nih.gov/8827069
Publikováno v:
Medical and pediatric oncology. 27(5)
Wilms' tumor-specific loss of heterozygosity (LOH) for DNA markers located at chromosomes 11p13, 11p15, 16q, and 1p has been reported to occur in a minority of Wilms' tumors. We hypothesized that tumors classified by region of LOH would exhibit speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0df3bcff5673e9b2e627b34cd8f1c382
https://pubmed.ncbi.nlm.nih.gov/8926924
https://pubmed.ncbi.nlm.nih.gov/8926924
Publikováno v:
Medical and pediatric oncology. 26(3)
The purpose of this study was to evaluate the effect of the sequential addition of doxorubicin and cyclophosphamide to the combination of vincristine and actinomycin D on the relapse-free survival of children with stage IV/favorable histology Wilms t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f3e0f86ad6985d0ec14c70818a10c36
https://pubmed.ncbi.nlm.nih.gov/8544795
https://pubmed.ncbi.nlm.nih.gov/8544795
Autor:
M L, Ritchey, D M, Green, P R, Thomas, G R, Smith, G, Haase, S, Shochat, J, Moksness, N E, Breslow
Publikováno v:
Medical and pediatric oncology. 26(2)
This report defines the incidence and determines the etiology of renal failure (RF) in patients undergoing treatment for Wilms' tumor (WT). The database of the National Wilms' Tumor Study (NWTS) was searched to identify all children reported to have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad99d442832d815cbd6dda1c94426325
https://pubmed.ncbi.nlm.nih.gov/9024526
https://pubmed.ncbi.nlm.nih.gov/9024526
Publikováno v:
Cancer. 75(2)
Five percent of patients with Wilms' tumor will present with bilateral disease. Recent reports suggest that preoperative imaging studies can exclude contralateral disease reliably, obviating the need for formal surgical exploration of the contralater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::618d23c6782db29a341d2e5ebdc448a7
https://pubmed.ncbi.nlm.nih.gov/7812929
https://pubmed.ncbi.nlm.nih.gov/7812929
Publikováno v:
Journal of the National Cancer Institute. Monographs. (19)
National Wilms' Tumor Study-4 was designed to evaluate the efficacy, toxicity, and cost of administration of different regimens for the treatment of Wilms' tumor. The charges for treatment with dactinomycin and doxorubicin administered by two differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e58cd79a5803020767d1227d28d85fa
https://pubmed.ncbi.nlm.nih.gov/7577200
https://pubmed.ncbi.nlm.nih.gov/7577200
Publikováno v:
Cancer. 74(6)
The purpose of this study was to determine the relationship between histologic microsubstaging variables, patient age, and tumor specimen weight in patients with Stage I/favorable histology Wilms' tumors.The authors reviewed all randomized patients f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67584904054a6f7a5e0a0f040dace089
https://pubmed.ncbi.nlm.nih.gov/8082084
https://pubmed.ncbi.nlm.nih.gov/8082084
Publikováno v:
Cancer research. 54(9)
We have prospectively analyzed Wilms' tumors from 232 patients registered on the National Wilms' Tumor Study for loss of heterozygosity (LOH) on chromosomes 11p, 16q, and 1p. These chromosomal aberrations were found in 70 (33%), 35 (17%), and 21 (12%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18d05c4992d0313810e4369f2f3af077
https://pubmed.ncbi.nlm.nih.gov/8162576
https://pubmed.ncbi.nlm.nih.gov/8162576